カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のイミペネムAPI市場2022年：無菌API、非滅菌API

◆英語タイトル：Global Imipenem API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8851 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：111 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

イミペネムAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のイミペネムAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

イミペネムAPI市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・無菌API、非滅菌API

用途別セグメントは次のように区分されます。
・筋肉内注射、静的ドロップ

世界のイミペネムAPI市場の主要な市場プレーヤーは以下のとおりです。
・Hospira、ACS DOBFAR SPA、High Science、Jeil Pharmaceutica、Choongwae Pharma Corporation、Sun Pharmaceutical、Sandoz、Kaliberr、Auronext Pharma、Nectar Lifesciences、Savior Lifetec Corporation、Zhuhai United Laboratorie、SUZHOU HOMESUN PHARMACEUTICAL、Unimark Remedies、Zhejiang Haixiang Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、イミペネムAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なイミペネムAPIメーカーの企業概要、2019年～2022年までのイミペネムAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なイミペネムAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別イミペネムAPIの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのイミペネムAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのイミペネムAPI市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびイミペネムAPIの産業チェーンを掲載しています。
・第13、14、15章では、イミペネムAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Hospira、ACS DOBFAR SPA、High Science、Jeil Pharmaceutica、Choongwae Pharma Corporation、Sun Pharmaceutical、Sandoz、Kaliberr、Auronext Pharma、Nectar Lifesciences、Savior Lifetec Corporation、Zhuhai United Laboratorie、SUZHOU HOMESUN PHARMACEUTICAL、Unimark Remedies、Zhejiang Haixiang Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：無菌API、非滅菌API
・用途別分析2017年-2028年：筋肉内注射、静的ドロップ
・イミペネムAPIの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・イミペネムAPIのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・イミペネムAPIのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・イミペネムAPIの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・イミペネムAPIの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Imipenem API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Imipenem API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Intramuscular Injection accounting for % of the Imipenem API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Aseptic API segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Imipenem API include Hospira, ACS DOBFAR SPA, High Science, Jeil Pharmaceutica, and Choongwae Pharma Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Imipenem API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aseptic API
Non-sterile API
Market segment by Application can be divided into
Intramuscular Injection
Static Drops
The key market players for global Imipenem API market are listed below:
Hospira
ACS DOBFAR SPA
High Science
Jeil Pharmaceutica
Choongwae Pharma Corporation
Sun Pharmaceutical
Sandoz
Kaliberr
Auronext Pharma
Nectar Lifesciences
Savior Lifetec Corporation
Zhuhai United Laboratorie
SUZHOU HOMESUN PHARMACEUTICAL
Unimark Remedies
Zhejiang Haixiang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Imipenem API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Imipenem API, with price, sales, revenue and global market share of Imipenem API from 2019 to 2022.
Chapter 3, the Imipenem API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Imipenem API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Imipenem API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Imipenem API.
Chapter 13, 14, and 15, to describe Imipenem API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Imipenem API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imipenem API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Aseptic API
1.2.3 Non-sterile API
1.3 Market Analysis by Application
1.3.1 Overview: Global Imipenem API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Intramuscular Injection
1.3.3 Static Drops
1.4 Global Imipenem API Market Size & Forecast
1.4.1 Global Imipenem API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Imipenem API Sales in Volume (2017-2028)
1.4.3 Global Imipenem API Price (2017-2028)
1.5 Global Imipenem API Production Capacity Analysis
1.5.1 Global Imipenem API Total Production Capacity (2017-2028)
1.5.2 Global Imipenem API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Imipenem API Market Drivers
1.6.2 Imipenem API Market Restraints
1.6.3 Imipenem API Trends Analysis
2 Manufacturers Profiles
2.1 Hospira
2.1.1 Hospira Details
2.1.2 Hospira Major Business
2.1.3 Hospira Imipenem API Product and Services
2.1.4 Hospira Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 ACS DOBFAR SPA
2.2.1 ACS DOBFAR SPA Details
2.2.2 ACS DOBFAR SPA Major Business
2.2.3 ACS DOBFAR SPA Imipenem API Product and Services
2.2.4 ACS DOBFAR SPA Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 High Science
2.3.1 High Science Details
2.3.2 High Science Major Business
2.3.3 High Science Imipenem API Product and Services
2.3.4 High Science Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Jeil Pharmaceutica
2.4.1 Jeil Pharmaceutica Details
2.4.2 Jeil Pharmaceutica Major Business
2.4.3 Jeil Pharmaceutica Imipenem API Product and Services
2.4.4 Jeil Pharmaceutica Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Choongwae Pharma Corporation
2.5.1 Choongwae Pharma Corporation Details
2.5.2 Choongwae Pharma Corporation Major Business
2.5.3 Choongwae Pharma Corporation Imipenem API Product and Services
2.5.4 Choongwae Pharma Corporation Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sun Pharmaceutical
2.6.1 Sun Pharmaceutical Details
2.6.2 Sun Pharmaceutical Major Business
2.6.3 Sun Pharmaceutical Imipenem API Product and Services
2.6.4 Sun Pharmaceutical Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Imipenem API Product and Services
2.7.4 Sandoz Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Kaliberr
2.8.1 Kaliberr Details
2.8.2 Kaliberr Major Business
2.8.3 Kaliberr Imipenem API Product and Services
2.8.4 Kaliberr Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Auronext Pharma
2.9.1 Auronext Pharma Details
2.9.2 Auronext Pharma Major Business
2.9.3 Auronext Pharma Imipenem API Product and Services
2.9.4 Auronext Pharma Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Nectar Lifesciences
2.10.1 Nectar Lifesciences Details
2.10.2 Nectar Lifesciences Major Business
2.10.3 Nectar Lifesciences Imipenem API Product and Services
2.10.4 Nectar Lifesciences Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Savior Lifetec Corporation
2.11.1 Savior Lifetec Corporation Details
2.11.2 Savior Lifetec Corporation Major Business
2.11.3 Savior Lifetec Corporation Imipenem API Product and Services
2.11.4 Savior Lifetec Corporation Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Zhuhai United Laboratorie
2.12.1 Zhuhai United Laboratorie Details
2.12.2 Zhuhai United Laboratorie Major Business
2.12.3 Zhuhai United Laboratorie Imipenem API Product and Services
2.12.4 Zhuhai United Laboratorie Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 SUZHOU HOMESUN PHARMACEUTICAL
2.13.1 SUZHOU HOMESUN PHARMACEUTICAL Details
2.13.2 SUZHOU HOMESUN PHARMACEUTICAL Major Business
2.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product and Services
2.13.4 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Unimark Remedies
2.14.1 Unimark Remedies Details
2.14.2 Unimark Remedies Major Business
2.14.3 Unimark Remedies Imipenem API Product and Services
2.14.4 Unimark Remedies Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Zhejiang Haixiang Pharmaceutical
2.15.1 Zhejiang Haixiang Pharmaceutical Details
2.15.2 Zhejiang Haixiang Pharmaceutical Major Business
2.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Product and Services
2.15.4 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Imipenem API Breakdown Data by Manufacturer
3.1 Global Imipenem API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Imipenem API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Imipenem API
3.4 Market Concentration Rate
3.4.1 Top 3 Imipenem API Manufacturer Market Share in 2021
3.4.2 Top 6 Imipenem API Manufacturer Market Share in 2021
3.5 Global Imipenem API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Imipenem API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Imipenem API Market Size by Region
4.1.1 Global Imipenem API Sales in Volume by Region (2017-2028)
4.1.2 Global Imipenem API Revenue by Region (2017-2028)
4.2 North America Imipenem API Revenue (2017-2028)
4.3 Europe Imipenem API Revenue (2017-2028)
4.4 Asia-Pacific Imipenem API Revenue (2017-2028)
4.5 South America Imipenem API Revenue (2017-2028)
4.6 Middle East and Africa Imipenem API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Imipenem API Sales in Volume by Type (2017-2028)
5.2 Global Imipenem API Revenue by Type (2017-2028)
5.3 Global Imipenem API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Imipenem API Sales in Volume by Application (2017-2028)
6.2 Global Imipenem API Revenue by Application (2017-2028)
6.3 Global Imipenem API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Imipenem API Sales by Type (2017-2028)
7.2 North America Imipenem API Sales by Application (2017-2028)
7.3 North America Imipenem API Market Size by Country
7.3.1 North America Imipenem API Sales in Volume by Country (2017-2028)
7.3.2 North America Imipenem API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Imipenem API Sales by Type (2017-2028)
8.2 Europe Imipenem API Sales by Application (2017-2028)
8.3 Europe Imipenem API Market Size by Country
8.3.1 Europe Imipenem API Sales in Volume by Country (2017-2028)
8.3.2 Europe Imipenem API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Imipenem API Sales by Type (2017-2028)
9.2 Asia-Pacific Imipenem API Sales by Application (2017-2028)
9.3 Asia-Pacific Imipenem API Market Size by Region
9.3.1 Asia-Pacific Imipenem API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Imipenem API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Imipenem API Sales by Type (2017-2028)
10.2 South America Imipenem API Sales by Application (2017-2028)
10.3 South America Imipenem API Market Size by Country
10.3.1 South America Imipenem API Sales in Volume by Country (2017-2028)
10.3.2 South America Imipenem API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Imipenem API Sales by Type (2017-2028)
11.2 Middle East & Africa Imipenem API Sales by Application (2017-2028)
11.3 Middle East & Africa Imipenem API Market Size by Country
11.3.1 Middle East & Africa Imipenem API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Imipenem API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Imipenem API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Imipenem API
12.3 Imipenem API Production Process
12.4 Imipenem API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Imipenem API Typical Distributors
13.3 Imipenem API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Imipenem API Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Imipenem API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Hospira Basic Information, Manufacturing Base and Competitors
Table 4. Hospira Major Business
Table 5. Hospira Imipenem API Product and Services
Table 6. Hospira Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. ACS DOBFAR SPA Basic Information, Manufacturing Base and Competitors
Table 8. ACS DOBFAR SPA Major Business
Table 9. ACS DOBFAR SPA Imipenem API Product and Services
Table 10. ACS DOBFAR SPA Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. High Science Basic Information, Manufacturing Base and Competitors
Table 12. High Science Major Business
Table 13. High Science Imipenem API Product and Services
Table 14. High Science Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Jeil Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 16. Jeil Pharmaceutica Major Business
Table 17. Jeil Pharmaceutica Imipenem API Product and Services
Table 18. Jeil Pharmaceutica Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Choongwae Pharma Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Choongwae Pharma Corporation Major Business
Table 21. Choongwae Pharma Corporation Imipenem API Product and Services
Table 22. Choongwae Pharma Corporation Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceutical Major Business
Table 25. Sun Pharmaceutical Imipenem API Product and Services
Table 26. Sun Pharmaceutical Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sandoz Basic Information, Manufacturing Base and Competitors
Table 28. Sandoz Major Business
Table 29. Sandoz Imipenem API Product and Services
Table 30. Sandoz Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Kaliberr Basic Information, Manufacturing Base and Competitors
Table 32. Kaliberr Major Business
Table 33. Kaliberr Imipenem API Product and Services
Table 34. Kaliberr Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Auronext Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Auronext Pharma Major Business
Table 37. Auronext Pharma Imipenem API Product and Services
Table 38. Auronext Pharma Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Nectar Lifesciences Basic Information, Manufacturing Base and Competitors
Table 40. Nectar Lifesciences Major Business
Table 41. Nectar Lifesciences Imipenem API Product and Services
Table 42. Nectar Lifesciences Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Savior Lifetec Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Savior Lifetec Corporation Major Business
Table 45. Savior Lifetec Corporation Imipenem API Product and Services
Table 46. Savior Lifetec Corporation Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Zhuhai United Laboratorie Basic Information, Manufacturing Base and Competitors
Table 48. Zhuhai United Laboratorie Major Business
Table 49. Zhuhai United Laboratorie Imipenem API Product and Services
Table 50. Zhuhai United Laboratorie Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. SUZHOU HOMESUN PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 52. SUZHOU HOMESUN PHARMACEUTICAL Major Business
Table 53. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product and Services
Table 54. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Unimark Remedies Basic Information, Manufacturing Base and Competitors
Table 56. Unimark Remedies Major Business
Table 57. Unimark Remedies Imipenem API Product and Services
Table 58. Unimark Remedies Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Zhejiang Haixiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Zhejiang Haixiang Pharmaceutical Major Business
Table 61. Zhejiang Haixiang Pharmaceutical Imipenem API Product and Services
Table 62. Zhejiang Haixiang Pharmaceutical Imipenem API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Imipenem API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (KG)
Table 64. Global Imipenem API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Imipenem API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Imipenem API Production Capacity by Company, (KG): 2020 VS 2021
Table 67. Head Office and Imipenem API Production Site of Key Manufacturer
Table 68. Imipenem API New Entrant and Capacity Expansion Plans
Table 69. Imipenem API Mergers & Acquisitions in the Past Five Years
Table 70. Global Imipenem API Sales by Region (2017-2022) & (KG)
Table 71. Global Imipenem API Sales by Region (2023-2028) & (KG)
Table 72. Global Imipenem API Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Imipenem API Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Imipenem API Sales by Type (2017-2022) & (KG)
Table 75. Global Imipenem API Sales by Type (2023-2028) & (KG)
Table 76. Global Imipenem API Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Imipenem API Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Imipenem API Price by Type (2017-2022) & (US$/G)
Table 79. Global Imipenem API Price by Type (2023-2028) & (US$/G)
Table 80. Global Imipenem API Sales by Application (2017-2022) & (KG)
Table 81. Global Imipenem API Sales by Application (2023-2028) & (KG)
Table 82. Global Imipenem API Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Imipenem API Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Imipenem API Price by Application (2017-2022) & (US$/G)
Table 85. Global Imipenem API Price by Application (2023-2028) & (US$/G)
Table 86. North America Imipenem API Sales by Country (2017-2022) & (KG)
Table 87. North America Imipenem API Sales by Country (2023-2028) & (KG)
Table 88. North America Imipenem API Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Imipenem API Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Imipenem API Sales by Type (2017-2022) & (KG)
Table 91. North America Imipenem API Sales by Type (2023-2028) & (KG)
Table 92. North America Imipenem API Sales by Application (2017-2022) & (KG)
Table 93. North America Imipenem API Sales by Application (2023-2028) & (KG)
Table 94. Europe Imipenem API Sales by Country (2017-2022) & (KG)
Table 95. Europe Imipenem API Sales by Country (2023-2028) & (KG)
Table 96. Europe Imipenem API Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Imipenem API Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Imipenem API Sales by Type (2017-2022) & (KG)
Table 99. Europe Imipenem API Sales by Type (2023-2028) & (KG)
Table 100. Europe Imipenem API Sales by Application (2017-2022) & (KG)
Table 101. Europe Imipenem API Sales by Application (2023-2028) & (KG)
Table 102. Asia-Pacific Imipenem API Sales by Region (2017-2022) & (KG)
Table 103. Asia-Pacific Imipenem API Sales by Region (2023-2028) & (KG)
Table 104. Asia-Pacific Imipenem API Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Imipenem API Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Imipenem API Sales by Type (2017-2022) & (KG)
Table 107. Asia-Pacific Imipenem API Sales by Type (2023-2028) & (KG)
Table 108. Asia-Pacific Imipenem API Sales by Application (2017-2022) & (KG)
Table 109. Asia-Pacific Imipenem API Sales by Application (2023-2028) & (KG)
Table 110. South America Imipenem API Sales by Country (2017-2022) & (KG)
Table 111. South America Imipenem API Sales by Country (2023-2028) & (KG)
Table 112. South America Imipenem API Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Imipenem API Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Imipenem API Sales by Type (2017-2022) & (KG)
Table 115. South America Imipenem API Sales by Type (2023-2028) & (KG)
Table 116. South America Imipenem API Sales by Application (2017-2022) & (KG)
Table 117. South America Imipenem API Sales by Application (2023-2028) & (KG)
Table 118. Middle East & Africa Imipenem API Sales by Region (2017-2022) & (KG)
Table 119. Middle East & Africa Imipenem API Sales by Region (2023-2028) & (KG)
Table 120. Middle East & Africa Imipenem API Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Imipenem API Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Imipenem API Sales by Type (2017-2022) & (KG)
Table 123. Middle East & Africa Imipenem API Sales by Type (2023-2028) & (KG)
Table 124. Middle East & Africa Imipenem API Sales by Application (2017-2022) & (KG)
Table 125. Middle East & Africa Imipenem API Sales by Application (2023-2028) & (KG)
Table 126. Imipenem API Raw Material
Table 127. Key Manufacturers of Imipenem API Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Imipenem API Typical Distributors
Table 131. Imipenem API Typical Customers
List of Figures
Figure 1. Imipenem API Picture
Figure 2. Global Imipenem API Revenue Market Share by Type in 2021
Figure 3. Aseptic API
Figure 4. Non-sterile API
Figure 5. Global Imipenem API Revenue Market Share by Application in 2021
Figure 6. Intramuscular Injection
Figure 7. Static Drops
Figure 8. Global Imipenem API Revenue, (USD Million) & (KG): 2017 & 2021 & 2028
Figure 9. Global Imipenem API Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Imipenem API Sales (2017-2028) & (KG)
Figure 11. Global Imipenem API Price (2017-2028) & (US$/G)
Figure 12. Global Imipenem API Production Capacity (2017-2028) & (KG)
Figure 13. Global Imipenem API Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Imipenem API Market Drivers
Figure 15. Imipenem API Market Restraints
Figure 16. Imipenem API Market Trends
Figure 17. Global Imipenem API Sales Market Share by Manufacturer in 2021
Figure 18. Global Imipenem API Revenue Market Share by Manufacturer in 2021
Figure 19. Imipenem API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Imipenem API Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Imipenem API Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Imipenem API Sales Market Share by Region (2017-2028)
Figure 23. Global Imipenem API Revenue Market Share by Region (2017-2028)
Figure 24. North America Imipenem API Revenue (2017-2028) & (USD Million)
Figure 25. Europe Imipenem API Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Imipenem API Revenue (2017-2028) & (USD Million)
Figure 27. South America Imipenem API Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Imipenem API Revenue (2017-2028) & (USD Million)
Figure 29. Global Imipenem API Sales Market Share by Type (2017-2028)
Figure 30. Global Imipenem API Revenue Market Share by Type (2017-2028)
Figure 31. Global Imipenem API Price by Type (2017-2028) & (US$/G)
Figure 32. Global Imipenem API Sales Market Share by Application (2017-2028)
Figure 33. Global Imipenem API Revenue Market Share by Application (2017-2028)
Figure 34. Global Imipenem API Price by Application (2017-2028) & (US$/G)
Figure 35. North America Imipenem API Sales Market Share by Type (2017-2028)
Figure 36. North America Imipenem API Sales Market Share by Application (2017-2028)
Figure 37. North America Imipenem API Sales Market Share by Country (2017-2028)
Figure 38. North America Imipenem API Revenue Market Share by Country (2017-2028)
Figure 39. United States Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Imipenem API Sales Market Share by Type (2017-2028)
Figure 43. Europe Imipenem API Sales Market Share by Application (2017-2028)
Figure 44. Europe Imipenem API Sales Market Share by Country (2017-2028)
Figure 45. Europe Imipenem API Revenue Market Share by Country (2017-2028)
Figure 46. Germany Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Imipenem API Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Imipenem API Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Imipenem API Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Imipenem API Revenue Market Share by Region (2017-2028)
Figure 55. China Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Imipenem API Sales Market Share by Type (2017-2028)
Figure 62. South America Imipenem API Sales Market Share by Application (2017-2028)
Figure 63. South America Imipenem API Sales Market Share by Country (2017-2028)
Figure 64. South America Imipenem API Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Imipenem API Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Imipenem API Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Imipenem API Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Imipenem API Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Imipenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Imipenem API in 2021
Figure 76. Manufacturing Process Analysis of Imipenem API
Figure 77. Imipenem API Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のイミペネムAPI市場2022年：無菌API、非滅菌API(Global Imipenem API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のイミペネムAPI市場2022年：無菌API、非滅菌API

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp